Health ❯Healthcare ❯Obesity

Treatment Options

GLP-1 Medications Novo Nordisk Semaglutide Medication Efficacy GLP-1 Agonists Zepbound Chronic Disease Management GLP-1 Receptor Agonists Weight Loss Surgery Wegovy Incretin-based Therapies GLP-1 Drugs Lifestyle Changes Hormonal Therapies Weight Loss Medications Medication Tirzepatide Mounjaro and Ozempic Semaglutide Approval Anti-Obesity Drugs Zepbound (tirzepatide)

Poll Shows Americans Divided Over Weight-Loss Drugs for Obesity Treatment

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Medicare to Cover Eli Lilly’s Zepbound for Sleep Apnea Treatment

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

Limited Access to Popular Weight-Loss Drugs Highlights Socioeconomic Disparities

Ozempic Shows Promising Mental Health and Cognitive Benefits

New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients